All Pathways
Infectious DiseaseManagement

Osteomyelitis Management (IDSA 2015)

Osteomyelitis Management (IDSA 2015): Suspected Osteomyelitis → Imaging → Bone Biopsy/Culture → Type of Osteomyelitis → Vertebral Osteomyelitis.

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Osteomyelitis

    Bone pain, fever, elevated inflammatory markers

    1. Action

      Imaging

      MRI is gold standard

      • MRI: Sensitivity/specificity >90%
      • CT if MRI contraindicated
      • Plain films: May be negative early
      • Bone scan: If MRI not available
      1. Action

        Bone Biopsy/Culture

        Essential for targeted therapy

        • CT-guided or surgical biopsy
        • Culture + histopathology
        • Hold antibiotics 2 weeks before if possible
        • Blood cultures (positive in ~50% hematogenous)
        1. Decision

          Type of Osteomyelitis

          1. Action

            Vertebral Osteomyelitis

            Hematogenous spread common

            • MRI entire spine
            • Blood cultures often positive
            • S. aureus most common
            • Immobilization/bracing
            1. Action

              Empiric Antibiotics

              Start after cultures obtained

              • MSSA: Nafcillin/Oxacillin 2g IV q4h or Cefazolin 2g IV q8h
              • MRSA: Vancomycin 15-20mg/kg q12h or Daptomycin 6-8mg/kg
              • GNR: Ceftriaxone or FQ
              • Narrow to culture results
              1. Decision

                Surgical Debridement Needed?

                Necrotic bone, hardware, abscess

                1. Action

                  Surgical Debridement

                  Remove necrotic/infected bone

                  • Curettage or excision
                  • Hardware removal if infected
                  • May need staged procedures
                  1. Action

                    Duration of Therapy

                    6 weeks typically

                    • Vertebral: 6 weeks IV (may switch to PO)
                    • Long bone: 4-6 weeks
                    • DFO with residual bone: Longer/indefinite suppression
                    • After surgical debridement: 4-6 weeks
                    1. Outcome

                      Resolved

                      ESR/CRP normalizing, imaging improved

                    2. Warning

                      Treatment Failure/Relapse

                      Re-biopsy, surgery, suppressive therapy

                2. Action

                  Medical Management Alone

                  If no surgical indication

          2. Action

            Contiguous (Non-vertebral)

            Adjacent soft tissue infection

            • Often post-surgical/trauma
            • Debridement usually required
            • Polymicrobial common
            • DFO: Probe-to-bone test
          3. Action

            Hematogenous (Long Bone)

            Children > adults

            • Search for primary source
            • S. aureus predominant
            • May respond to antibiotics alone

Guideline Source

IDSA Vertebral Osteomyelitis Guidelines 2015

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • ⚠️ UNVALIDATED DRAFT: This algorithm was AI-generated from guideline summaries and has NOT been reviewed by clinical experts. All doses, thresholds, and pathways MUST be verified against primary sources by qualified clinicians before clinical use. Do not use for patient care without expert validation.
  • Bone biopsy preferred for definitive diagnosis
  • Duration depends on surgical debridement
  • Vertebral vs long bone differs

Applicable Regions

USEU
Version 1Next review: 2027-01-11

Frequently Asked Questions

What is the Osteomyelitis Management (IDSA 2015)?

The Osteomyelitis Management (IDSA 2015) is a management clinical algorithm for Infectious Disease. It provides a structured decision tree to guide clinical decision-making, based on IDSA Vertebral Osteomyelitis Guidelines 2015.

What guideline is the Osteomyelitis Management (IDSA 2015) based on?

This algorithm is based on IDSA Vertebral Osteomyelitis Guidelines 2015 (DOI: 10.1093/cid/civ482).

What are the limitations of the Osteomyelitis Management (IDSA 2015)?

Known limitations include: ⚠️ UNVALIDATED DRAFT: This algorithm was AI-generated from guideline summaries and has NOT been reviewed by clinical experts. All doses, thresholds, and pathways MUST be verified against primary sources by qualified clinicians before clinical use. Do not use for patient care without expert validation.; Bone biopsy preferred for definitive diagnosis; Duration depends on surgical debridement; Vertebral vs long bone differs. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Osteomyelitis Management (IDSA 2015) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free